Biomedicines,
Journal Year:
2024,
Volume and Issue:
13(1), P. 47 - 47
Published: Dec. 28, 2024
Gastrointestinal
tumors
present
a
significant
challenge
for
precision
medicine
due
to
their
complexity,
necessitating
the
development
of
more
specific
diagnostic
tools
and
therapeutic
agents.
Recent
advances
have
positioned
coding
non-coding
RNAs
as
emerging
biomarkers
these
malignancies,
detectable
by
liquid
biopsies,
innovative
Many
RNA-based
therapeutics,
such
small
interfering
RNA
(siRNA)
antisense
oligonucleotides
(ASO),
entered
clinical
trials
or
are
available
on
market.
This
review
provides
narrative
examination
potential
in
gastrointestinal
cancers,
with
an
emphasis
its
application
medicine.
discusses
current
challenges,
drug
resistance
tumor
metastasis,
highlights
how
molecules
can
be
leveraged
targeted
detection
treatment.
Additionally,
this
categorizes
targets
based
tissue
type,
offering
comprehensive
analysis
role
advancing
tumors.
Journal of Controlled Release,
Journal Year:
2024,
Volume and Issue:
370, P. 239 - 255
Published: April 27, 2024
Double
pH-responsive
xenopeptide
carriers
containing
succinoyl
tetraethylene
pentamine
(Stp)
and
lipo
amino
fatty
acids
(LAFs)
were
evaluated
for
CRISPR/Cas9
based
genome
editing.
Different
carrier
topologies,
variation
of
LAF/Stp
ratios
LAF
types
as
Cas9
mRNA/sgRNA
polyplexes
screened
in
three
different
reporter
cell
lines
using
genomic
targets
(Pcsk9,
eGFP,
mdx
exon
23).
One
U-shaped
bundle
(B2)-shaped
lipo-xenopeptides
exhibiting
remarkable
efficiencies
identified.
Genome
editing
potency
top
observed
at
sub-nanomolar
EC
European Journal of Pharmaceutical Sciences,
Journal Year:
2024,
Volume and Issue:
205, P. 106983 - 106983
Published: Dec. 7, 2024
Clustered
regularly
interspaced
short
palindromic
repeat
(CRISPR)/CRISPR
associated
(Cas)
protein
has
been
proved
as
a
powerful
tool
for
the
treatment
of
genetic
diseases.
The
Cas9
protein,
when
combined
with
single-guide
RNA
(sgRNA),
forms
Cas9/sgRNA
ribonucleoprotein
(RNP)
capable
targeting
and
editing
genome.
However,
limited
availability
effective
carriers
restricted
broader
application
CRISPR/Cas9
RNP.
In
this
study,
we
evaluated
dual
pH-responsive
amphiphilic
xenopeptides
(XPs)
delivering
These
artificial
lipo-XPs
contain
apolar
cationizable
lipoamino
fatty
acid
(LAF)
polar
oligoaminoethylene
units
such
succinoyl-tetraethylenepentamine
(Stp)
in
various
ratios
U-shaped
topologies.
were
screened
functional
RNP
delivery
four
different
reporter
cell
lines,
including
Duchenne
muscular
dystrophy
(DMD)
exon
skipping
model.
Significantly
enhanced
cellular
uptake
into
HeLa
cells,
endosomal
disruption
gal8-mRuby3
potent
genome
by
several
complexes
was
observed
lines
5
nM
sgRNA
range.
Comparing
mRNA/sgRNA
polyplexes
DMD
model
demonstrated
similar
splice
site
high
two
molecular
modalities.
Based
on
these
studies,
analogues
U1
LAF2-Stp
LAF4-Stp2
structures
deployed,
tuning
amphiphilicity
Stp
group
replacement
six
oligoamino
acids
dmGtp,
chGtp,
dGtp,
Htp,
Stt,
or
GEIPA.
most
(containing
chGtp
GEIPA)
further
gene
efficiency
EC50
values
1
line.
Notably,
LAF2-dGtp
reached
0.51
even
upon
serum
incubation.
Another
carrier
(LAF4-GEIPA2)
complexing
donor
DNA,
facilitated
up
to
43
%
homology-directed
repair
(HDR)
eGFPd2
cells
visualized
switch
from
green
fluorescent
(eGFP)
blue
(BFP).
This
study
presents
system
tunable
RNP/donor
DNA
polyplexes,
offering
an
easily
applicable
strategy
editing.
Frontiers in Drug Delivery,
Journal Year:
2024,
Volume and Issue:
4
Published: Aug. 15, 2024
RNA
therapy
is
a
rapidly
expanding
field
and
has
great
promise
in
achieving
targeted
gene
silencing
contributing
to
personalized
medicine.
However,
the
delivery
of
molecules
into
organs
or
cells
still
challenging.
To
overcome
this
hurdle,
number
nanocarriers
with
pros
cons
have
been
developed.
This
study
was
designed
develop
simple
cost-effective
approach
functionalize
biodegradable
magnetic
iron
nanoparticles
(MNPs)
for
cell-specific
siRNA
delivery.
MNPs
were
synthesized
based
on
co-precipitation
further
functionalized
sodium
citrate
polyethyleneimine
(PEI)
followed
by
material
characterization
using
TEM,
FTIR,
Zeta
potential.
The
PEI-coated
conjugated
CD31
antibody
complexed
linker-free
approach.
siRNA-loaded
successfully
knocked
down
expression
GAPDH
human
endothelial
(ECs)
NOTCH3
vascular
smooth
muscle
(VSMCs).
In
an
EC
VSMC
co-culture
system
under
shear
stress
mimic
blood
flow,
specifically
delivered
ECs.
Our
represents
versatile
platform
that
could
be
adopted
general
Biomacromolecules,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 26, 2024
Quinine-based
polymers
have
previously
demonstrated
promising
performance
in
delivering
pDNA
cells
owing
to
their
electrostatic
as
well
the
nonelectrostatic
interactions
with
pDNA.
Herein,
we
evaluate
whether
quinine-based
are
versatile
for
delivery
of
mRNA
and
Cas9-sgRNA
complexes,
especially
a
serum-rich
environment.
Both
complex
potent
therapeutics
that
structurally,
chemically,
functionally
very
different
from
By
exploring
family
7
vary
monomer
structure
polymer
composition,
tested
numerous
formulations
(42
pDNA,
96
mRNA,
48
Cas9-sgRNA)
payload-polymer
complexation
compare
payload-dependent
structure-activity
relationships.
Several
comparable
or
better
than
commercially
available
transfection
agent
jetPEI.
The
results
this
study
demonstrate
potential
carrier
platform
wide
range
nucleic
acid
serving
drug
needs
field
genetic
medicine.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(8), P. 1028 - 1028
Published: Aug. 1, 2024
Immunotherapy
combats
tumors
by
enhancing
the
body's
immune
surveillance
and
clearance
of
tumor
cells.
Various
nucleic
acid
drugs
can
be
used
in
immunotherapy,
such
as
DNA
expressing
cytokines,
mRNA
vaccines,
small
interfering
RNAs
(siRNA)
knocking
down
immunosuppressive
molecules,
oligonucleotides
that
adjuvants.
Nucleic
drugs,
which
are
prone
to
nuclease
degradation
circulation
find
it
difficult
enter
target
cells,
typically
necessitate
developing
appropriate
vectors
for
effective
vivo
delivery.
Biomimetic
drug
delivery
systems,
derived
from
viruses,
bacteria,
protect
cargos
clearance,
deliver
them
cells
ensure
safety.
Moreover,
they
activate
system
through
their
endogenous
activities
active
components,
thereby
improving
efficacy
antitumor
immunotherapeutic
drugs.
In
this
review,
biomimetic
systems
relieving
a
microenvironment
introduced.
Their
activation
mechanisms,
including
upregulating
proinflammatory
serving
inhibiting
checkpoints,
modulating
intratumoral
elaborated.
The
advantages
disadvantages,
well
possible
directions
clinical
translation,
summarized
at
last.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 12389 - 12407
Published: Nov. 1, 2024
Infected
bone
defects
pose
a
challenging
clinical
issue
due
to
an
imbalance
of
osteoclasts
(OC)
and
osteoblasts
(OB).
Exosomes
are
crucial
for
intercellular
signaling
OC
OB
in
repair.
Icariin,
has
been
shown
regulate
the
balance
between
OB.
However,
specific
mechanisms
by
which
icariin
influences
exosomes
derived
from
osteoclasts,
subsequently
impacts
osteoblast
activity,
remain
unclear.
This
study
aims
investigate
effects
icariin-treated
osteoclast-derived
(ICA-OC-Exo)
on
function
repair
cases
infected
defects.